Sinovac Biotech Reaches New 1-Year Low at $4.61 (SVA)
Sinovac Biotech (NYSE:SVA)’s share price reached a new 52-week low on Tuesday , AmericanBankingNews.com reports. The company traded as low as $4.61 and last traded at $5.07, with a volume of 1,203,330 shares. The stock had previously closed at $5.53.
Separately, analysts at Aegis raised their price target on shares of Sinovac Biotech from $7.00 to $10.00 in a research note on Friday, August 15th. They now have a “buy” rating on the stock.
The stock has a 50-day moving average of $5.58 and a 200-day moving average of $6.10. The company has a market cap of $279.4 million and a price-to-earnings ratio of 55.86.
Sinovac Biotech (NYSE:SVA) last released its earnings data on Thursday, August 14th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by $0.05. The company had revenue of $12.10 million for the quarter, compared to the consensus estimate of $17.20 million. Analysts expect that Sinovac Biotech will post $-0.04 EPS for the current fiscal year.
Sinovac Biotech Ltd. (NYSE:SVA) is a holding company.
Receive News & Ratings for Sinovac Biotech Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinovac Biotech Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.